And yet there are compounds that have shown effectivness POST exposure to ebola.
http://www.ncbi.nlm.nih.gov/pubmed/24583123
That particular compound is already in phase III clinical trials as an anti-influenza drug.
Yep, that one is further along than most, but for a different disease. Most of the other drugs have not been efficacy tested in humans at all, for any indication.
It is so terrible, that patients can only receive supportive care. It does seem to help, since the death rate from this outbreak is “only” about 60%, which is significantly lower than that seen in other outbreaks—up to 90%.
Yep, that one is further along than most, but for a different disease. Most of the other drugs have not been efficacy tested in humans at all, for any indication.
It is so terrible, that patients can only receive supportive care. It does seem to help, since the death rate from this outbreak is “only” about 60%, which is significantly lower than that seen in other outbreaks—up to 90%.